Continuous Ambulatory Delivery Device Use for Patients Managed by an Inpatient Palliative Care Team
Pain Management Nursing · 2024
DOI: 10.1016/j.pmn.2024.02.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pain Management Nursing, 2024. Verfasst von Madison Peters und 2 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Practice Nurse, Division of Palliative Care Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Palliative Care, Pain Management, Analgesia, Patient-Controlled. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Palliativpflege
Abstract (Originalsprache)
BACKGROUND: The use of Patient Controlled Analgesia (PCA) via a Continuous Ambulatory Delivery Device (CADD) is a common and effective means of pain and symptom management for hospitalized patients with a malignancy. Studies exploring the indications for starting such a device for hospitalized inpatients referred to inpatient palliative care teams are limited. AIM: This retrospective chart review aims to explore indications, timing of initiation, and barriers to the use of a CADD. METHODS: Over a six month period, during daily inpatient palliative care consult team rounds, patients who required a CADD were enrolled in this study. Sixty-one adult patients were identified who required a pump for symptom control. The team's database sheets were used to capture patient demographics. RESULTS: The main reasons for initiating a Continuous Ambulatory Delivery Device in the above setting included: lack of efficacy of oral opioids and to increase patient autonomy of their pain management. Approximately 20% of patients required transfer to another unit that could accommodate the CADD. The median length of stay for these patients was 13 days, with a median length of half a day for a pump to be started. CONCLUSIONS: This initial study provides the Palliative Care Consult Team with information on the indications for the use of a CADD. The lack of universal access to a CADD in various areas of our hospital due to differences in departmental protocols may compromise good symptom management and patient safety. These results strengthen the argument that the existing hospital policy requires revamping to improve CADD access. A CADD has been shown to provide hospitalized patients, with a malignancy, with timely access to effective symptom management, and in turn, reducing their length of stay in hospital. These findings will help inform this organization's CADD policy and support the need to broaden access to this device.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Advanced Practice Nurse, Division of Palliative Care Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
- Palliative Care Physician, Division of Supportive and Palliative Care, Brampton Civic Hospital, William Osler Health System, Brampton, Ontario, Canada; Senior Lecturer, University of Queensland, Brisbane, Australia.
- Advanced Practice Nurse, Division of Palliative Care Sunnybrook Health Sciences Centre, Adjunct Clinical Faculty for Lawrence Bloomberg Faculty of Nursing, University of Toronto, Toronto, Ontario, Canada. Electronic add…
Zitieren
APA
Peters, M., Kutzko, D. J., & Stilos, K. (2024). Continuous Ambulatory Delivery Device Use for Patients Managed by an Inpatient Palliative Care Team. Pain Management Nursing. https://doi.org/10.1016/j.pmn.2024.02.014
Vancouver
Peters M, Kutzko DJ, Stilos K. Continuous Ambulatory Delivery Device Use for Patients Managed by an Inpatient Palliative Care Team. Pain Management Nursing. 2024. doi:10.1016/j.pmn.2024.02.014
BibTeX
@article{Peters2024,
author = {Peters, Madison and Kutzko, Dr Justin and Stilos, Kalli},
title = {Continuous Ambulatory Delivery Device Use for Patients Managed by an Inpatient Palliative Care Team},
journal = {Pain Management Nursing},
year = {2024},
doi = {10.1016/j.pmn.2024.02.014}
}
EUVIMED